The market for biocompatibility and immunomodulation, critical considerations in the development of biomedical devices and materials, is witnessing significant growth. This is driven by increasing prevalence of chronic diseases, aging populations, and advances in biomaterials science. While exact market size figures are challenging to delineate due to the intersectionality of fields, the overall biomaterials market, underpinned by biocompatibility and immunomodulation, is expected to reach $297 billion by 2022 according to a report by MarketsandMarkets. Despite potential regulatory and biocompatibility challenges, the escalating demand for innovative medical implants and therapies offer considerable opportunities.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by